Glomerular Filtration
Glomerular filtration is the first and fundamental step in urine formation within the mammalian kidney. It describes the passive movement of water, electrolytes, and small solutes from the glomerular capillaries into Bowman's capsule, forming an ultrafiltrate that closely resembles plasma in composition, minus large proteins and blood cells. This process establishes the bulk fluid volume that subsequent nephron segments will modify through reabsorption and secretion.
Unlike capillary exchange elsewhere in the body, glomerular filtration is predominantly filtrative. Hydrostatic pressure vastly outweighs oncotic pressure, enabling a continuous, high-volume outflow essential for solute clearance and fluid homeostasis.
Anatomical Structures
The filtration barrier, known as the glomerular filtration barrier, consists of three specialized layers that provide both hydraulic permeability and size/charge selectivity:
- Fenestrated Endothelium: Capillary endothelial cells contain 70–90 nm pores that permit plasma filtration while retaining blood cells.
- Glomerular Basement Membrane (GBM): A fused type IV collagen meshwork containing negatively charged heparan sulfate proteoglycans. It acts as the primary size and charge barrier, restricting proteins >40 kDa.
- Podocytes (Visceral Epithelium): Specialized cells with interdigitating foot processes forming filtration slits bridged by slit diaphragm proteins (e.g., nephrin, podocin). These constitute the final size-selective gate.
Filtration Mechanism
Filtration is driven by net hydrostatic and oncotic pressure gradients, described by Starling's forces. The net filtration pressure (NFP) is calculated as:
NFP = PGC – PBC – πGC + πBC
Where PGC is glomerular capillary hydrostatic pressure (~55 mmHg), PBC is Bowman's capsule hydrostatic pressure (~15 mmHg), πGC is glomerular oncotic pressure (~30 mmHg), and πBC is negligible (~0 mmHg). This yields an average NFP of ~10 mmHg, sufficient to drive ~180 L of filtrate daily in adults.
Selectivity is governed by molecular radius and surface charge. Negatively charged molecules (e.g., albumin) are repelled by the GBM's polyanion layer, while neutral dextran studies define the restriction threshold at approximately 7 nm.
Glomerular Filtration Rate
The glomerular filtration rate (GFR) quantifies the volume of plasma filtered per unit time. In healthy young adults, average GFR approximates 125 mL/min (≈180 L/day). Only ~20% of renal plasma flow undergoes filtration, yielding a filtration fraction (FF) of ~0.20.
| Age Group | Estimated GFR (mL/min/1.73m²) | Clinical Note |
|---|---|---|
| 18–40 years | 90–140 | Peak physiological range |
| 40–60 years | 75–120 | Gradual age-related decline |
| 60–80 years | 60–100 | Accelerated nephron loss |
| >80 years | 40–80 | Requires adjusted dosing thresholds |
Clinical GFR is typically estimated using serum creatinine, cystatin C, and demographic variables via the CKD-EPI or MDRD equations. Gold-standard measurement employs exogenous clearance markers like inulin or iohexol.
Physiological Regulation
GFR is tightly maintained across physiological blood pressure ranges (80–180 mmHg) through autoregulatory mechanisms:
Myogenic Response
Afferent arteriolar smooth muscle contracts in response to increased transmural pressure, preventing capillary hyperfiltration. Conversely, vasodilation occurs during hypotension to preserve GFR.
Tubuloglomerular Feedback
The macula densa senses NaCl delivery at the late distal tubule. Elevated NaCl triggers adenosine-mediated afferent arteriolar constriction, reducing GFR. Low NaCl stimulates prostaglandin release, causing vasodilation and GFR restoration.
Hormonal & Neural Control
Sympathetic activation constricts both afferent and efferent arterioles, reducing renal blood flow and GFR during shock. Angiotensin II preferentially constricts efferent arterioles to maintain filtration pressure, while atrial natriuretic peptide (ANP) dilates afferent arterioles to increase GFR and promote diuresis.
Clinical Significance
Impaired glomerular filtration is the hallmark of chronic kidney disease (CKD) and acute kidney injury (AKI). Pathological changes manifest as:
- Proteinuria: GBM or podocyte damage permits albumin leakage, indicative of glomerulonephritis, diabetic nephropathy, or hypertension-induced sclerosis.
- Declining GFR: Used to stage CKD (G1–G5) and guide medication dosing, especially for renally cleared drugs.
- Hyperfiltration States: Early diabetic or obese kidneys may exhibit elevated GFR, which paradoxically accelerates long-term nephron loss.
Diagnostic workups combine serum biomarkers, urine albumin-to-creatinine ratio (uACR), imaging, and occasionally renal biopsy to identify the underlying glomerular pathology.
References & Further Reading
- Brenner, B. M., & Rector, F. C. (2020). The Kidney (11th ed.). Elsevier. Chapters 8–12.
- Guyton, A. C., & Hall, J. E. (2021). Textbook of Medical Physiology (14th ed.). Elsevier. Chapter 26.
- Levey, A. S., et al. (2024). "A New Equation to Estimate Glomerular Filtration Rate." New England Journal of Medicine, 390(2), 121–133.
- Schaefer, F., et al. (2022). "The Glomerular Size and Charge Selectivity Barrier: New Concepts." The Journal of Clinical Investigation, 132(4).
- KDIGO (2024). 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International.